Essen Tech Co., Ltd. (KOSDAQ:043340)
568.00
-39.00 (-6.43%)
At close: Feb 26, 2026
Essen Tech Revenue
Essen Tech had revenue of 13.14B KRW in the quarter ending September 30, 2025, with 18.32% growth. This brings the company's revenue in the last twelve months to 55.99B, up 7.12% year-over-year. In the year 2024, Essen Tech had annual revenue of 54.37B with 14.13% growth.
Revenue (ttm)
55.99B
Revenue Growth
+7.12%
P/S Ratio
1.01
Revenue / Employee
368.38M
Employees
152
Market Cap
56.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 54.37B | 6.73B | 14.13% |
| Dec 31, 2023 | 47.64B | -14.93B | -23.86% |
| Dec 31, 2022 | 62.57B | 5.98B | 10.56% |
| Dec 31, 2021 | 56.60B | 6.58B | 13.15% |
| Dec 31, 2020 | 50.02B | -1.69B | -3.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Korea Arlico Pharm | 205.21B |
| IGLOO | 119.42B |
| Mercury | 115.33B |
| Milae Bioresources | 64.06B |
| The Lamy | 63.54B |
| I&C Technology | 35.21B |
| Precision Biosensor | 19.74B |
| HASS Corp. | 17.18B |